À propos
Partner and Patent Attorney in Mewburn Ellis's chemistry team with over 25 years' experience focused on pharmaceutical chemistry, covering invention capture, drafting, global prosecution, opposition and freedom-to-operate. He has drafted and globally prosecuted patent portfolios for two marketed oncology drugs (one a blockbuster with six patents listed in the FDA Orange Book) and is also a leading member of the firm's designs team, advising clients from start-ups and universities to multinational pharmaceutical companies.
Domaines d’expertise
Intellectual PropertyPatentsPatent ProsecutionLife SciencesPharmaceuticalsDesigns
Bureau
Expertise
Antibody-drug conjugatesSmall-molecule pharmaceuticalsPolymorphic forms of drugsCombination therapiesOncology drugsInvention capturePatent draftingGlobal prosecutionOppositionFreedom-to-operateAdvising start-ups and spin-outsWorking with universities, charities, SMEs and multinational pharmaceutical companies
Formation
- First-class degree in Chemistry, Oxford University
Inscriptions au barreau
- Chartered Patent Attorney (qualified 1999)
- European Patent Attorney (qualified 1999)
- Professional Representative before the EUIPO (1999–2020)